Cell Engineering
Souvie Biodelivery is focused on developing a novel drug delivery platform technology that transports drug payload to and into the cells to which it is targeted, while having almost no effect on healthy tissues. Our exosome-based platform to support drug delivery, embodied in an innovative exosome-based therapy for the treatment of chronic auto-immune diseases and sepsis. Exosome-based therapeutics represent a novel class of biologics to treat human diseases.